In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans.
about
Inhibition of RNA synthesis as a therapeutic strategy against Aspergillus and Fusarium: demonstration of in vitro synergy between rifabutin and amphotericin B.Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitisThe past, present and future of antimycotic combination therapy.Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitisPneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitroCombination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitisEffect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitisIn vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azolesCombination treatment of invasive fungal infections.In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates.In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methodsIn vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreusIn vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.Combinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays.Pulmonary cryptococcosis in late pregnancy and review of published literature.In vitro and in vivo experimental activities of antifungal agents against Fusarium solani.In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach.Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolatesIn vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models.In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus.Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China.Potentiation of antifungal activity of amphotericin B by azithromycin against Aspergillus species.
P2860
Q33690848-9235CBA6-8794-4155-AD11-F1E648FA7E05Q33690866-E1EA57BC-2D91-486B-B4BB-C35BF3CB7419Q33760507-B401771D-D767-4F04-98F0-010BEE0A5524Q35102525-8F86DFF9-C539-4AD1-8368-D10D238EB68FQ35127069-F6F9474A-DD11-44B8-AB5F-83641FBE0EA5Q35132244-51A971CA-CF27-46A4-93EE-CEADAD5C8EE0Q35136158-E7ED76ED-68B7-45FB-B5B6-7A45C4F5EDC2Q35137341-B641FF8D-E68A-49EC-8D97-07EC28017714Q35137828-39331362-B592-4DEF-BBEC-303A0791B189Q36011378-74426B77-A138-4A68-B7B9-3EC5A18DB7DAQ36047748-D96A83D2-3ECE-4278-A881-09F2BC64F021Q36425093-359A8BCE-0B7F-47E8-A6D4-78AFADA84E1EQ36492208-A5503D7D-B0A4-46BF-AA3D-1910508149BFQ36558484-FA481D47-005F-4692-850B-878EE7711B37Q36911369-4F2063B1-03DD-4E25-BBB3-4CBDF0ABAA87Q37302834-8A058FF9-EE03-4C38-A18A-3A64A1D56712Q39470710-9E05104F-C19E-46A2-9303-ED1AF18A59D8Q39652783-0A3D5F9E-B863-419F-83D6-4B41E50A437DQ39653016-49F11E83-D428-4EA3-86D4-108CA0BC6224Q40882541-432044FC-D085-4A93-8A3E-569A2C6CEDE1Q41772012-D20F660D-B619-4410-84C9-6A27E55AEDBAQ45017876-5BBFE3CC-51E0-4F5E-BE42-F7B840A35106Q54148822-0EFE01C5-30B8-4EEA-A21F-F1B39280985E
P2860
In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans.
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
In vitro evaluation of combina ...... us neoformans var. neoformans.
@ast
In vitro evaluation of combina ...... us neoformans var. neoformans.
@en
type
label
In vitro evaluation of combina ...... us neoformans var. neoformans.
@ast
In vitro evaluation of combina ...... us neoformans var. neoformans.
@en
prefLabel
In vitro evaluation of combina ...... us neoformans var. neoformans.
@ast
In vitro evaluation of combina ...... us neoformans var. neoformans.
@en
P2093
P2860
P356
P1476
In vitro evaluation of combina ...... us neoformans var. neoformans.
@en
P2093
P2860
P304
P356
10.1128/AAC.39.8.1691
P407
P577
1995-08-01T00:00:00Z